Open access
Aug 2026
Targeting the PHB2–ACSL3 Lipid‐Remodeling Axis Overcomes Cisplatin Resistance by Restoring Ferroptosis in Gastric Cancer
A PHB2–ACSL3 lipid‐metabolic axis that drives ferroptosis escape is defined and Mavorixafor repurposing is identified as an immediately translatable strategy to overcome cisplatin resistance in treatment‐refractory GC.
Liang Xu, Wanying Xiang, Xinyue Wang et al.
· Advancement of science · 0 citations